X

pharmaceuticals

Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform

Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be…

Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice…

Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock…

Earnings Summary: A snapshot of Catalent’s Q3 2023 results

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for…

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said…

Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results

Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite…

Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharmaceutical company focused on clinical programs in oncology, fibrosis, infectious disease, and inflammation.…

Ocean Biomedical (OCEA) set to join the Russell 2000 Index

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,…

Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment

Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad…

Ocean Biomedical announces private placement of $25 mln convertible notes

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a…

MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter…

Catalyst Pharmaceuticals Inc (CPRX) Q1 2023 Earnings Call Transcript

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q1 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer…

Jazz Pharmaceuticals PLC (JAZZ) Q1 2023 Earnings Call Transcript

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Andrea Flynn -- Vice President and Head, Investor…

A snapshot of McKesson Corporation’s Q4 2023 earnings

Healthcare service provider McKesson Corporation (NYSE: MCK) announced financial results for the fourth quarter of 2023, reporting a 4% increase…

ANI Pharmaceuticals Inc (ANIP) Q1 2023 Earnings Call Transcript

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- Chief Executive…

Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite…

Zoetis Inc (ZTS) Q1 2023 Earnings Call Transcript

Zoetis Inc (NYSE:ZTS) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Steve Frank -- Vice President of Investor…

Key highlights from Moderna’s (MRNA) Q1 2023 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today. Total revenue was $1.9 billion, compared to $6.1 billion…

Regeneron Pharmaceuticals Inc (REGN) Q1 2023 Earnings Call Transcript

Regeneron Pharmaceuticals Inc  (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations…

Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023

Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter…